Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director
-
Issuer Symbol
-
MIRM on Nasdaq
Patrick J. Heron - trading volume in the past year for Mirum Pharmaceuticals, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
3,566,912 |
$281,750,378 |
$78.99 |
23 Jan 2026 |
By Frazier Life Sciences IX, L.P. |
|
|
| Common Stock |
459,010 |
$31,433,004 |
$68.48 |
23 Jan 2026 |
By Frazier Life Sciences X, L.P. |
|
|
| Common Stock |
5,703 |
$450,479 |
$78.99 |
23 Jan 2026 |
Direct |
|
|
| Restricted Stock Units |
0 |
$146,453 |
$25.68 |
29 May 2025 |
Direct |
Common Stock |
|
| Stock Option (right to buy) |
6,268 |
|
|
29 May 2025 |
Direct |
Common Stock |
|
| Deferred Stock Units |
3,977 |
|
|
29 May 2025 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.